Product Reports Resources Pricing Login Book a demo

Invuity

Health Tech & Medtech · San Francisco, United States · Founded 2004 · IPO 2015

A medical technology company focused on pioneering the use of advanced photonics to provide surgeons with improved direct visualization of surgical cavities during open minimally invasive and minimal… MoreLess

Invuity, Inc. operated as a medical technology company, establishing a notable presence in the advanced surgical devices market before its acquisition. Founded in 2004 by Alex Vayser and headquartered in San Francisco, California, the firm focused on enhancing surgical procedures through superior visualization. The company's core offering was its patented Intelligent Photonics technology, a sophisticated system designed to illuminate surgical cavities during minimally invasive operations. This technology utilized proprietary optical waveguides to provide broad, uniform, and thermally cool light, enabling surgeons to work with greater precision, safety, and efficiency, particularly in deep and dark surgical sites.

The business model centered on the development and sale of single-use, lighted surgical instruments. Its product portfolio included a variety of retractors, handheld devices, and drop-in illuminators. These tools were applied across a wide range of clinical specialties, including orthopedic and spine surgery, gynecology, breast cancer and reconstructive surgery, thyroid procedures, and general surgery. The company's clients were primarily hospitals and surgeons who perceived the products as differentiated, allowing Invuity to command premium pricing. The firm went public in June 2015 and had raised a total of $99.1 million in funding over several rounds from investors such as HealthCare Royalty Partners, Wellington, and Valence Life Sciences.

A significant milestone in the company's history was its acquisition by Stryker Corporation. The definitive agreement was announced in September 2018, with Stryker acquiring all outstanding shares of Invuity for approximately $190 million. The acquisition was completed in October 2018, after which Invuity became a wholly-owned subsidiary of Stryker and its shares were delisted from NASDAQ. The move was seen as highly complementary to Stryker's instruments business, combining its leadership in minimal access surgery with Invuity's visualization technology to improve patient outcomes and operating room efficiencies.

Keywords: surgical visualization, medical photonics, minimal access surgery, lighted surgical instruments, surgical devices, intelligent photonics, surgical retractors, operating room efficiency, surgical safety, medical technology, Stryker acquisition, orthopedic surgery, spine surgery, women's health surgery, breast reconstruction, single-use medical devices, advanced surgical devices, surgical illumination, direct visualization, medtech

Valuation $0–100M
Revenue $10–50M
Total funding $100–500M

Talent graph

Invuity's talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Invuity's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 5 investors entered at this stage
Valence Life Sciences
InterWest Partners
Wexford Capital
HealthCare Royalty
Wellington Management

Global footprint

Where Invuity has talent and traffic

Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

What the market is saying about Invuity

An AI-synthesized read of the highest-engagement posts about Invuity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Invuity on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.